Abbott Laboratories vs. Dividend Monarchs
This is a US news story, published by Yahoo Finance, that relates primarily to ABT news.
US news
For more US news, you can click here:
more US newsstocks trading & speculation news
For more stocks trading & speculation news, you can click here:
more stocks trading & speculation newsYahoo Finance news
For more news from Yahoo Finance, you can click here:
more news from Yahoo FinanceAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best business news, entertainment news, world news, and much more. If you like stocks trading & speculation news, you might also like this article about
Best Dividend Monarchs. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest Dividend Monarchs news, Dividend Kings news, stocks trading & speculation news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
Dividend Monarchs IndexInsider Trading & Hedge Fund Data, and Investment Newsletter From Insider Monkey
•Business
Business & Economics
Is Abbott Laboratories (ABT) the Best Dividend Monarch to Invest in Now?
84% Informative
The Dividend Monarchs Index highlights US companies that have managed to raise their dividends consistently for at least 50 consecutive years .
S&P Dow Jones Indices has been a pioneer in dividend growth strategies since the 1980s , initially tracking US companies with at least 10 years of dividend growth.
Abbott Laboratories ( NYSE : ABT ) recently announced that its Volt PFA System , designed to treat atrial fibrillation—a common heart condition—has received CE mark approval in Europe .
Abbott Laboratories ( NYSE : ABT ) currently pays a quarterly dividend of $ 0.59 per share and has a dividend yield of 1.87% , as of April 15 .
Since the start of 2025 , the stock has surged by over 11% .
ABT ranks 7th on our list of the best Dividend Monarchs to invest in.
VR Score
90
Informative language
93
Neutral language
14
Article tone
formal
Language
English
Language complexity
55
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
long-living
External references
5
Source diversity
1
Affiliate links
no affiliate links
Small business owner?